Hypertriglyceridemia in the Genomic Era: A New Paradigm
The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Hypertriglyceridemia (HTG) is a highly prevalent condition that is associated with increased cardiovascular disease risk. HTG may arise as a result of defective metabolism of triglyceride-rich lipoproteins and their remnants, ie, impaired clearance, or increased production, or both. Current categorization of HTG segregates primary and secondary cases, implying genetic and nongenetic causes for each category. Many common and rare variants of the genes encoding factors involved in these pathways have been identified. Although monogenic forms of HTG do occur, most cases are polygenic and often coexist with nongenetic conditions. Cumulative, multiple genetic variants can increase the risks for HTG, whereas environmental and lifestyle factors can force expression of a dyslipidemic phenotype in a genetically susceptible person. HTG states are therefore best viewed as a complex phenotype resulting from the interaction of cumulated multiple susceptibility genes and environmental stressors. In view of the heterogeneity of the HTG states, the absence of a unifying metabolic or genetic abnormality, overlap with the metabolic syndrome and other features of insulin resistance, and evidence in some patients that accumulation of numerous small-effect genetic variants determines whether an individual is susceptible to HTG only or to HTG plus elevated low-density lipoprotein cholesterol, we propose that the diagnosis of primary HTG and further delineation of familial combined hyperlipidemia from familial HTG is neither feasible nor clinically relevant at the present time. The hope is that with greater understanding of genetic and environmental causes and their interaction, therapy can be intelligently targeted in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mendelian randomization studies also suggest that the association between plasma TGs and the risk of CHD may be causal; however, this evidence must be interpreted with caution because nearly all variants associated with TGs are also associated with HDL-C, LDL-C, or Lp(a) [56-59].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [57]
Citations
Cites
1 retracted
Doolittle, M. H., Neher, S. B., Ben-Zeev, O., Ling-liao, J., Gallagher, C. M., Hosseini, M., Yin, F., Wong, H., Walter, P., & Péterfy, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049395 · Cited by 29
RetractedThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Willer (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
Brown adipose tissue activity controls triglyceride clearance
Bartelt, A., Bruns, O. T., Reimer, R., Hohenberg, H., Ittrich, H., Peldschus, K., Kaul, M. G., Tromsdorf, U. I., Weller, H., Waurisch, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2297 · Cited by 1,608
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,443
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333
Self-citationChapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,093
Self-citationLoss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
The TG and HDL Working Group of the Exome Sequencing Project, N. H. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1307095 · Cited by 1,071
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308027 · Cited by 919
Common variants associated with plasma triglycerides and risk for coronary artery disease
Do, R., Willer, C. J., Schmidt, E. M., Sengupta, S., Gao, C., Peloso, G. M., Gustafsson, S., Kanoni, S., Ganna, A., Chen, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2795 · Cited by 862
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
(2010) · The Lancet · doi:10.1016/s0140-6736(10)60545-4 · Cited by 716
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
Do, R., Stitziel, N. O., Won, H.-H., Jørgensen, A. B., Duga, S., Angelica Merlini, P., Kiezun, A., Farrall, M., Goel, A., Zuk, O., et al. (2015) · Nature · doi:10.1038/nature13917 · Cited by 650
Self-citationHegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., Borén, J., Bruckert, E., Catapano, A. L., Descamps, O. S., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70191-8 · Cited by 635
Self-citationHypertriglyceridemia: its etiology, effects and treatment
Yuan, G., Al-Shali, K. Z., & Hegele, R. A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060963 · Cited by 624
Self-citationPhysiological regulation of lipoprotein lipase
Kersten, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.03.013 · Cited by 550
Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002
Carroll, M. D. (2005) · JAMA · doi:10.1001/jama.294.14.1773 · Cited by 531
Lewis, G. F., Uffelman, K. D., Szeto, L. W., Weller, B., & Steiner, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117633 · Cited by 502
Self-citationJørgensen, A. B., Frikke-Schmidt, R., West, A. S., Grande, P., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs431 · Cited by 501
Brunzell, J. D., Hazzard, W. R., Porte, D., & Bierman, E. L. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107334 · Cited by 484
Hyperlipidemia in Coronary Heart Disease
Goldstein, J. L., HAzzmm, W. R., ScinoTT, H. G., Bierman, E. L., Levinski, M. J., & Campbell, E. D. (1973) · Cited by 471
Plasma lipoproteins: genetic influences and clinical implications
Hegele, R. A. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2481 · Cited by 462
Self-citationBeigneux, A. P., Davies, B. S. J., Gin, P., Weinstein, M. M., Farber, E., Qiao, X., Peale, F., Bunting, S., Walzem, R. L., Wong, J. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.02.002 · Cited by 445
Resnick, H. E., Foster, G. L., Bardsley, J., & Ratner, R. E. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-1254 · Cited by 428
Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
Choi, S. H., & Ginsberg, H. N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.007 · Cited by 418
Dynamics of human adipose lipid turnover in health and metabolic disease
Arner, P., Bernard, S., Salehpour, M., Possnert, G., Liebl, J., Steier, P., Buchholz, B. A., Eriksson, M., Arner, E., Hauner, H., et al. (2011) · Nature · doi:10.1038/nature10426 · Cited by 400
Intestinal lipid absorption and lipoprotein formation
Hussain, M. M. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000084 · Cited by 363
Laakso, M., Lehto, S., Penttilä, I., & Pyörälä, K. (1993) · Circulation · doi:10.1161/01.cir.88.4.1421 · Cited by 301
Kissebah, A. H., Alfarsi, S., & Adams, P. W. (1981) · Metabolism · doi:10.1016/0026-0495(81)90064-0 · Cited by 295
FAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASE
Nikkilä, E., & Aro, A. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91598-5 · Cited by 292
Grundy, S. M., Mok, H. Y. I., Zech, L., Steinberg, D., & Berman, M. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109422 · Cited by 283
Brunzell, J. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070061 · Cited by 268
Genetic determinants of plasma triglycerides
Johansen, C. T., Kathiresan, S., & Hegele, R. A. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009720 · Cited by 263
Self-citationMutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia
Surendran, R. P., Visser, M. E., Heemelaar, S., Wang, J., Peter, J., Defesche, J. C., Kuivenhoven, J. A., Hosseini, M., Péterfy, M., Kastelein, J. J. P., et al. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02516.x · Cited by 249
Self-citationDeitch, R. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91664-0 · Cited by 249
Siler, S. Q., Neese, R. A., & Hellerstein, M. K. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.5.928 · Cited by 231
Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
Karpe, F., Steiner, G., Olivecrona, T., Carlson, L. A., & Hamsten, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116293 · Cited by 230
Atherogenicity of Triglyceride-Rich Lipoproteins
Krauss, R. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00032-0 · Cited by 227
Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein
Packard, C. J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311066 · Cited by 225
Zheng, C., Khoo, C., Furtado, J., & Sacks, F. M. (2010) · Circulation · doi:10.1161/circulationaha.109.875807 · Cited by 223
Maio, A., & Dowd, F. J. (2010) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60628-2 · Cited by 209
Lee, J., & Hegele, R. A. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9665-4 · Cited by 202
Self-citationLEWIS, G. F., O'MEARA, N. M., SOLTYS, P. A., BLACKMAN, J. D., IVERIUS, P. H., PUGH, W. L., GETZ, G. S., & POLONSKY, K. S. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-4-934 · Cited by 202
Self-citationEffects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man.
Crouse, J. R., & Grundy, S. M. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37800-7 · Cited by 201
Xiao, C., Giacca, A., & Lewis, G. F. (2011) · Diabetes · doi:10.2337/db10-1433 · Cited by 197
Self-citationLipoprotein Metabolism in Pregnancy, Fat Transport to the Fetus, and the Effects of Diabetes
Knopp, R. H., Warth, M. R., Charles, D., Childs, M., Li, J. R., Mabuchi, H., & Van Allen, M. I. (2009) · Biology of the Neonate · doi:10.1159/000242614 · Cited by 193
Kissebah, A. H., Alfarsi, S., Evans, D. J., & Adams, P. W. (1982) · Diabetes · doi:10.2337/diab.31.3.217 · Cited by 191
Severe hypertriglyceridemia in pregnancy
Goldberg, A. S., & Hegele, R. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1250 · Cited by 187
Self-citationDuez, H., Lamarche, B., Uffelman, K. D., Valero, R., Cohn, J. S., & Lewis, G. F. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000222015.76038.14 · Cited by 187
Self-citationAlcohol and plasma triglycerides
Klop, B., Rego, A. T. D., & Cabezas, M. C. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283606845 · Cited by 177
Effect of Dietary Carbohydrate on Triglyceride Metabolism in Humans
Parks, E. J. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.10.2772s · Cited by 172
Sundaram, M., Zhong, S., Khalil, M. B., Links, P. H., Zhao, Y., Iqbal, J., Hussain, M. M., Parks, R. J., Wang, Y., & Yao, Z. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m900346-jlr200 · Cited by 171
Cohn, J. S., Patterson, B. W., Uffelman, K. D., Davignon, J., & Steiner, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032056 · Cited by 170
Ruidavets, J.-B., Ducimetiere, P., Evans, A., Montaye, M., Haas, B., Bingham, A., Yarnell, J., Amouyel, P., Arveiler, D., Kee, F., et al. (2010) · BMJ · doi:10.1136/bmj.c6077 · Cited by 170
Marcais, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24471 · Cited by 169
Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase
Beigneux, A. P., Franssen, R., Bensadoun, A., Gin, P., Melford, K., Peter, J., Walzem, R. L., Weinstein, M. M., Davies, B. S. J., Kuivenhoven, J. A., et al. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186577 · Cited by 161
Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects
Taskinen, M.-R., Adiels, M., Westerbacka, J., Söderlund, S., Kahri, J., Lundbom, N., Lundbom, J., Hakkarainen, A., Olofsson, S.-O., Orho-Melander, M., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.224808 · Cited by 153
Molecular mechanisms of lipid disorders in nephrotic syndrome
Vaziri, N. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00941.x · Cited by 152
Chan, D. C., Watts, G. F., Redgrave, T. G., Mori, T. A., & Barrett, P. H. R. (2002) · Metabolism · doi:10.1053/meta.2002.33339 · Cited by 149
Mendivil, C. O., Zheng, C., Furtado, J., Lel, J., & Sacks, F. M. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.197830 · Cited by 145
Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype
Rose, H. G., Kranz, P., Weinstock, M., Juliano, J., & Haft, J. I. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90218-0 · Cited by 143
Panarotto, D., Rémillard, P., Bouffard, L., & Maheux, P. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00945.x · Cited by 137
Brahm, A., & Hegele, R. (2013) · Nutrients · doi:10.3390/nu5030981 · Cited by 136
Self-citationIntestinal lipoprotein overproduction in insulin-resistant states
Adeli, K., & Lewis, G. F. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282ffaf82 · Cited by 130
Self-citationHogue, J.-C., Lamarche, B., Tremblay, A. J., Bergeron, J., Gagné, C., & Couture, P. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600548-jlr200 · Cited by 129
Gut-liver interaction in triglyceride-rich lipoprotein metabolism
Xiao, C., Hsieh, J., Adeli, K., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2011 · Cited by 127
Self-citationDuvillard, L. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00702.x · Cited by 124
Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins
Melish, J., Le, N. A., Ginsberg, H., Steinberg, D., & Brown, W. V. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.239.5.e354 · Cited by 121
Pisciotta, L., Favari, E., Magnolo, L., Simonelli, S., Adorni, M. P., Sallo, R., Fancello, T., Zavaroni, I., Ardigò, D., Bernini, F., et al. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.960674 · Cited by 120
Baggio, G., Manzato, E., Gabelli, C., Fellin, R., Martini, S., Enzi, G. B., Verlato, F., Baiocchi, M. R., Sprecher, D. L., & Kashyap, M. L. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112332 · Cited by 119
Xiao, C., Giacca, A., & Lewis, G. F. (2007) · Diabetologia · doi:10.1007/s00125-007-0859-x · Cited by 118
Self-citationDuez, H., Lamarche, B., Valéro, R., Pavlic, M., Proctor, S., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2008) · Circulation · doi:10.1161/circulationaha.107.739888 · Cited by 115
Self-citationPlasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
Batal, R., Tremblay, M., Barrett, P. H. R., Jacques, H., Fredenrich, A., Mamer, O., Davignon, J., & Cohn, J. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32379-8 · Cited by 113
Basel‐Vanagaite, L., Zevit, N., Har‐Zahav, A., Guo, L., Parathath, S., Pasmanik‐Chor, M., McIntyre, A. D., Wang, J., Albin‐Kaplanski, A., Hartman, C., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.028 · Cited by 113
Self-citationThe genetics of familial combined hyperlipidaemia
Brouwers, M. C. G. J., van Greevenbroek, M. M. J., Stehouwer, C. D. A., de Graaf, J., & Stalenhoef, A. F. H. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.15 · Cited by 109
Pavlic, M., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2010) · Diabetes · doi:10.2337/db09-1297 · Cited by 102
Self-citationJohansen, C. T., Wang, J., Lanktree, M. B., McIntyre, A. D., Ban, M. R., Martins, R. A., Kennedy, B. A., Hassell, R. G., Visser, M. E., Schwartz, S. M., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226365 · Cited by 97
Self-citationSevere Hypertriglyceridemia Influenced by Alcohol (SHIBA)
Bessembinders, K., Wielders, J., & van de Wiel, A. (2011) · Alcohol and Alcoholism · doi:10.1093/alcalc/agq088 · Cited by 95
Genetics of familial combined hyperlipidemia and risk of coronary heart disease
Shoulders, C. C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh069 · Cited by 95
Fisher, E. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.02.001 · Cited by 92
Regulation of chylomicron production in humans
Xiao, C., & Lewis, G. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.019 · Cited by 91
Self-citationGPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons
Young, S. G., Davies, B. S., Fong, L. G., Gin, P., Weinstein, M. M., Bensadoun, A., & Beigneux, A. P. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3281527914 · Cited by 87
Batista, M. C., Welty, F. K., Diffenderfer, M. R., Sarnak, M. J., Schaefer, E. J., Lamon‐Fava, S., Asztalos, B. F., Dolnikowski, G. G., Brousseau, M. E., & Marsh, J. B. (2004) · Metabolism · doi:10.1016/j.metabol.2004.05.001 · Cited by 87
Dyslipidemia and nephrotic syndrome: recent advances.
Kronenberg, F. (2005) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2004.10.003 · Cited by 85
Chan, D. C., Watts, G. F., Nguyen, M. N., & Barrett, P. H. R. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000203519.25116.54 · Cited by 70
Chan, D. C., Barrett, P. H. R., Ooi, E. M. M., Ji, J., Chan, D. T., & Watts, G. F. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1457 · Cited by 66
Martín-Campos, J. M., Roig, R., Mayoral, C., Martinez, S., Martí, G., Arroyo, J. A., Julve, J., & Blanco-Vaca, F. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.11.020 · Cited by 65
Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia
Cohn, J. S., Tremblay, M., Batal, R., Jacques, H., Rodriguez, C., Steiner, G. A., Mamer, O., & Davignon, J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.011 · Cited by 62
Overproduction of low density lipoproteins associated with coronary heart disease.
Kesaniemi, Y. A., & Grundy, S. M. (1983) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.3.1.40 · Cited by 62
Allelic and phenotypic spectrum of plasma triglycerides
Johansen, C. T., & Hegele, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.007 · Cited by 61
Self-citationShojaee-Moradie, F., Ma, Y., Lou, S., Hovorka, R., & Umpleby, A. M. (2013) · Diabetes · doi:10.2337/db13-0935 · Cited by 60
Novel Role of Enteral Monosaccharides in Intestinal Lipoprotein Production in Healthy Humans
Xiao, C., Dash, S., Morgantini, C., & Lewis, G. F. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300769 · Cited by 56
Self-citationAbsence of Acute Inhibitory Effect of Insulin on Chylomicron Production in Type 2 Diabetes
Nogueira, J.-P., Maraninchi, M., Béliard, S., Padilla, N., Duvillard, L., Mancini, J., Nicolay, A., Xiao, C., Vialettes, B., Lewis, G. F., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.242073 · Cited by 52
Self-citationPavlic, M., Valéro, R., Duez, H., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.169383 · Cited by 51
Self-citationThe Complex Genetic Basis of Plasma Triglycerides
Johansen, C. T., & Hegele, R. A. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0243-2 · Cited by 46
Self-citationKypreos, K. E., & Zannis, V. I. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500322-jlr200 · Cited by 45
Wong, A. T. Y., Chan, D. C., Pang, J., Watts, G. F., & Barrett, P. H. R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2477 · Cited by 38
Alshali, K. Z., Wang, J., Fellows, F., Huff, M. W., Wolfe, B. M. J., & Hegele, R. A. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00283-7 · Cited by 37
Self-citationKinetic studies to investigate lipoprotein metabolism
Borén, J., Taskinen, M. ‐., & Adiels, M. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02497.x · Cited by 34
Xiao, C., Giacca, A., & Lewis, G. F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00313.2009 · Cited by 27
Self-citationDual Defect in Metabolism of Very-Low-Density Lipoprotein Triglycerides
Kesäniemi, Y. A. (1984) · JAMA · doi:10.1001/jama.251.19.2542 · Cited by 25
Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · PubMed Central · Cited by 20
Xiao, C., Giacca, A., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00183.2011 · Cited by 19
Self-citationOoi, E. M. M., Russell, B. S., Olson, E., Sun, S. Z., Diffenderfer, M. R., Lichtenstein, A. H., Keilson, L., Barrett, P. H. R., Schaefer, E. J., & Sprecher, D. L. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.238493 · Cited by 16
Ooi, E. M. M., Janus, E. D., Grant, S. J., Sinclair, L. M. T., & R.Barrett, P. H. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m004705 · Cited by 16
Dual Defect in Metabolism of Very-Low-Density Lipoprotein Triglycerides
Kesäniemi, Y. A. (1984) · JAMA · doi:10.1001/jama.1984.03340430040026 · Cited by 15
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
The changing landscape of atherosclerosis
Libby, P. (2021) · Nature · doi:10.1038/s41586-021-03392-8 · Cited by 2,873
Clinical review on triglycerides
Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz785 · Cited by 544
“Adapted from Ref.”
MethodInfluentialSelf-citationA Modern Approach to Dyslipidemia
Berberich, A. J., & Hegele, R. A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab037 · Cited by 469
Self-citation
Metadata
- Authors
- Lewis, G. F., Xiao, C., & Hegele, R. A.
- Affiliations
- University of Toronto (CA)
- Western University (CA)
- Corresponding author
- Lewis, Gary F.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2015-02-01
- Volume
- 36
- Issue
- 1
- Pages
- 131-147
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2142850613
- Cited by
- 152
- References
- 113
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 14 · 2023: 9 · 2022: 14 · 2021: 19 · 2020: 22 · 2019: 17 · 2018: 12 · 2017: 15 · 2016: 13 · 2015: 8
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Genome Canada
- Canadian Institutes of Health Research (79533, MOP‑79533), MOP13430, MOP-43839)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hypertriglyceridemia, triglyceride-rich lipoproteins, remnant lipoproteins, genetic susceptibility, polygenic inheritance, familial combined hyperlipidemia, familial hypertriglyceridemia, metabolic syndrome, insulin resistance, LDL cholesterol, gene-environment interaction, cardiovascular risk, dyslipidemia
- MeSH terms
- Alcohol Drinking, Diabetes Mellitus, Type 2, Environment, Female, Humans, Insulin Resistance, Life Style, Lipoproteins, Male, Metabolic Clearance Rate, Middle Aged, Nephrotic Syndrome, Phenotype, Pregnancy, Pregnancy Complications, Risk Factors, Triglycerides, Genetic Variation, Hypertriglyceridemia, Genetic Predisposition to Disease, Metabolic Syndrome, Atherosclerosis, Renal Insufficiency, Chronic, Obesity, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.